Symbols

Symbols

DYAI

DYAI

Dyadic International to Report Q2 2025 Financial Results Nov. 12, 2025.

Thursday Oct 23, 2025

Dyadic International: HC Wainwright Assumes Buy Rating, Sets PT at $3

Tuesday Oct 07, 2025

Dyadic Applied BioSolutions achieves milestone payments in collaborations, advances commercial focus.

Monday Oct 06, 2025

Dyadic achieves milestone payments, advances commercial focus, revenue growth.

Thursday Sep 04, 2025

Dyadic International to present at H.C. Wainwright and BioProcess International conferences.

Saturday Aug 16, 2025

Dyadic International Inc Reports Q2 2025 Earnings: Strategic Shifts, Market Expansion, and Financial Challenges

Wednesday Aug 13, 2025

Dyadic Sees $500K Milestone, Eyes Commercialization Push Through 2026

Dyadic International Narrows Q2 Loss, Completes Leadership Transformation and Rebrands as Dyadic Applied Biosolutions

Quest Diagnostics Declares Quarterly Cash Dividend of $0.80 per Share

Dyadic Reports Q2 2025 Financial Results, Completes $5.3mln Equity Offering.

Dyadic Reports Q2 2025 Financial Results, Highlights Leadership Transformation and Milestones in Life Sciences and Nutrition Markets.

Friday Aug 01, 2025

Dyadic International Closes $5.3 Million Stock Offering to Boost Working Capital

Dyadic International Announces Proposed Public Offering of Common Stock.

Thursday Jul 31, 2025

Dyadic prices 6.052mln shares, expects closing on Aug 1, 2025.

Dyadic International Launches Public Stock Offering, Shares Plummet 11.5%

Wednesday Jul 30, 2025

Dyadic International Announces Proposed Public Offering of Common Stock to Raise Funds for Working Capital and Product Development

Wednesday Jul 23, 2025

Dyadic International Receives Nasdaq Deficiency Notice: Compliance Deadline and Potential Delisting

Bazis Finance Reports Q3 2022 Earnings, Revenue Down 4.4%

Monday Jul 07, 2025

CervoMed's 15-min chart shows MACD Death Cross and Bearish Marubozu signals.

Friday Jul 04, 2025

Dyadic International to Rebrand as Dyadic Applied BioSolutions